CARCINOGENESIS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2022-04-17 ZZLLZZ

5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样

112 15 举报

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2022-02-15 1221c8e5m44(暂无昵称)

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：小RNA
经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。

6 8 举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2023-03-29 ms5000001856769052 来自北京

这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回

80 8 举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2019-08-14 半瓶不动满瓶摇

慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表::
我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表:
我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结

路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结

220 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2022-12-17 ms5000001856769052 来自北京

请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊

149 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2023-05-26 1212fed2m40(暂无昵称) 来自安徽省

这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？

110 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2021-01-31 1245e6c8m84暂无昵称

审稿速度:3.0 | 投稿命中率:50.0
经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用

210 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2024-05-03 ms9000001087203106 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。

102 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2023-06-15 Sswang0203 来自广东省

投稿后一周变成了Awaiting Decision Approval，要凉了吗

80 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212030, encodeId=cea9121203027, content=5天了，投的综述，一直Under Review，分配了编辑，没有送外审，不知道后面会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Sun Apr 17 23:14:45 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193505, encodeId=4975119350540, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：小RNA 经验分享：2021.9.28 submitted 2021.9.30 Under Review (编辑手里评估) 2021.9.30 Under review (外审) 2021.10.25 Awaiting decision 2021.10.30 Major revision 2021.11.11 submitted 2021.11.11 Under review 2022.1.11 Awaiting decision 2022.1.13 Accept upon revision 2022.1.17 submitted 20221.27 Accept 总体来说，审稿二审比较慢，一审大都1个月左右，审稿意见比较专业，会得到比较好的意见进行修改，接收后很快就可以挂网上了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ee2307349, createdName=1221c8e5m44(暂无昵称), createdTime=Tue Feb 15 10:10:06 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122493, encodeId=37042122493e8, content=这个期刊最近也太要命了，12.2投稿，快四个月了还没有消息，发邮件问也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Wed Mar 29 15:09:11 CST 2023, time=2023-03-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574806, encodeId=fec55e480608, content=慢慢投下来的，往下投过oncogene，cancer letters，到小cdd，一直被秒拒，不送外审，很悲剧，也请了发nature的专家看过，觉得6分问题不大，结果还是一直被拒，估计老外对这一块不感兴趣，直到这个杂志，才外审，小修接受。路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结林申申 2019-08-12 00:00:00 发表: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, beContent=路过人间 2019-08-12 发表:: 我去从cancer research一点点下来呢，还是直接投这个杂志？有点纠结, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27631958520, createdName=半瓶不动满瓶摇, createdTime=Wed Aug 14 00:00:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106449, encodeId=61242106449a4, content=请问各位大神，这个杂志怎么看有没有送外审啊，under review，ED: Not Assigned半个月了，啥意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Dec 17 12:33:31 CST 2022, time=2022-12-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2139242, encodeId=45ba2139242f6, content=这个杂志第二天就under review ，20天后又回到主编手上under Review，一直到今天都没有消息，一个月了。大家有没有碰到这类情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71cb2234962, createdName=1212fed2m40(暂无昵称), createdTime=Fri May 26 17:13:26 CST 2023, time=2023-05-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=921787, encodeId=f028921e872e, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：文章已经online.昨天收到邮件让交彩图的费用，各位大神是怎么操作的，不想交这个费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sun Jan 31 23:30:09 CST 2021, time=2021-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201590, encodeId=e00b2201590b4, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有幸刚中1篇，这杂志感觉效率很高，投稿1周就开始审稿，3周给了大修，审稿人整体对文章满意，编辑很严谨，对图表要求很细致，感觉像老牌杂志的风格。对中国人友好，速度快，比某些漂亮国杂志更值得推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=567e6155028, createdName=ms9000001087203106, createdTime=Fri May 03 12:50:53 CST 2024, time=2024-05-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2142874, encodeId=db9b21428e4c1, content=投稿后一周变成了Awaiting Decision Approval，要凉了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34732023541, createdName=Sswang0203, createdTime=Thu Jun 15 07:55:21 CST 2023, time=2023-06-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=562002, encodeId=0a6456200258, content=7天Awaiting Decision Approval，是不是要凉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Mon Oct 15 00:00:00 CST 2018, time=2018-10-15, status=1, ipAttribution=)]

2018-10-15 ms8000001455677582

7天Awaiting Decision Approval，是不是要凉

276 2 举报

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务